Clinical Trial Update: RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing SOX versus mFOLFOX6 in patients with resectable rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• MFOLFOX6
• SOX regimen (S-1 + oxaliplatin)

Snippet

Sponsor: Clinical Research Support Center Kyush | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN